메뉴 건너뛰기




Volumn 71, Issue 1, 2014, Pages 36-46

Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease

Author keywords

Glutamate; M100907; Microdialysis; MPTP; Parkinsonism; Serotonin

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; SEROTONIN; SEROTONIN 2A RECEPTOR; SODIUM CHLORIDE; TETRODOTOXIN; VOLINANSERIN; FLUOROBENZENE; PIPERIDINE DERIVATIVE; SEROTONIN 2 ANTAGONIST;

EID: 84899020554     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.03.016     Document Type: Article
Times cited : (6)

References (65)
  • 1
    • 0031006582 scopus 로고    scopus 로고
    • Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells
    • DOI 10.1016/S0028-3908(97)00051-8, PII S0028390897000518
    • G.K. Aghajanian, and G.J. Marek Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells Neuropharmacology 36 1997 589 599 (Pubitemid 27272104)
    • (1997) Neuropharmacology , vol.36 , Issue.4-5 , pp. 589-599
    • Aghajanian, G.K.1    Marek, G.J.2
  • 2
    • 0033577494 scopus 로고    scopus 로고
    • Serotonin, via 5-HT(2A) receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release
    • DOI 10.1016/S0006-8993(99)01224-X, PII S000689939901224X
    • G.K. Aghajanian, and G.J. Marek Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release Brain Res. 825 1999 161 171 (Pubitemid 29222872)
    • (1999) Brain Research , vol.825 , Issue.1-2 , pp. 161-171
    • Aghajanian, G.K.1    Marek, G.J.2
  • 3
    • 0037406047 scopus 로고    scopus 로고
    • Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats
    • DOI 10.1016/S0924-977X(03)00004-X
    • J. Ahlqvist, R. Isacson, C. Wahlestedt, and P. Salmi Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats Eur. Neuropsychopharmacol. 13 2003 177 182 (Pubitemid 36506927)
    • (2003) European Neuropsychopharmacology , vol.13 , Issue.3 , pp. 177-182
    • Ahlqvist, J.1    Isacson, R.2    Wahlestedt, C.3    Salmi, P.4
  • 4
    • 0035353725 scopus 로고    scopus 로고
    • Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
    • DOI 10.1002/mds.1090
    • J.E. Ahlskog, and M.D. Muenter Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov. Disord. 16 2001 448 458 (Pubitemid 36041148)
    • (2001) Movement Disorders , vol.16 , Issue.3 , pp. 448-458
    • Ahlskog, J.E.1    Muenter, M.D.2
  • 5
    • 0030175903 scopus 로고    scopus 로고
    • Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease
    • DOI 10.1006/neur.1996.0018
    • P. Anglade, A. Mouatt-Prigent, Y. Agid, and E. Hirsch Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease Neurodegeneration 5 1996 121 128 (Pubitemid 26248601)
    • (1996) Neurodegeneration , vol.5 , Issue.2 , pp. 121-128
    • Anglade, P.1    Mouatt-Prigent, A.2    Agid, Y.3    Hirsch, E.C.4
  • 6
    • 5444225824 scopus 로고    scopus 로고
    • 2A receptors in the D-amphetamine-induced release of dopamine: Comparison with previous data on α1b-adrenergic receptors
    • DOI 10.1111/j.1471-4159.2004.02714.x
    • A. Auclair, G. Blanc, J. Glowinski, and J.P. Tassin Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors J. Neurochem. 91 2004 318 326 (Pubitemid 39363431)
    • (2004) Journal of Neurochemistry , vol.91 , Issue.2 , pp. 318-326
    • Auclair, A.1    Blanc, G.2    Glowinski, J.3    Tassin, J.-P.4
  • 7
    • 0035869746 scopus 로고    scopus 로고
    • 2A receptors in afferents of the rat striatum
    • DOI 10.1002/1098-2396(20010315)39:4<297::AID-SYN1012>3.0.CO;2-Q
    • M. Bubser, J.R. Backstrom, E. Sanders-Bush, B.L. Roth, and A.Y. Deutch Distribution of serotonin 5-HT(2A) receptors in afferents of the rat striatum Synapse 39 2001 297 304 (Pubitemid 32128651)
    • (2001) Synapse , vol.39 , Issue.4 , pp. 297-304
    • Bubser, M.1    Backstrom, J.R.2    Sanders-Bush, E.3    Roth, B.L.4    Deutch, A.Y.5
  • 8
    • 42449117283 scopus 로고    scopus 로고
    • Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse
    • DOI 10.1111/j.1471-4159.2007.05185.x
    • C. Chassain, G. Bielicki, E. Durand, S. Lolignier, F. Essafi, A. Traore, and F. Durif Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse J. Neurochem. 105 2008 874 882 (Pubitemid 351562729)
    • (2008) Journal of Neurochemistry , vol.105 , Issue.3 , pp. 874-882
    • Chassain, C.1    Bielicki, G.2    Durand, E.3    Lolignier, S.4    Essafi, F.5    Traore, A.6    Durif, F.7
  • 9
    • 58149277182 scopus 로고    scopus 로고
    • Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats
    • E.K. Chung, L.W. Chen, Y.S. Chan, and K.K. Yung Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats J. Comp. Neurol. 511 2008 421 437
    • (2008) J. Comp. Neurol. , vol.511 , pp. 421-437
    • Chung, E.K.1    Chen, L.W.2    Chan, Y.S.3    Yung, K.K.4
  • 10
    • 0038323958 scopus 로고    scopus 로고
    • 2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats
    • DOI 10.1016/S0014-2999(03)01352-9
    • C. Corsi, A. Pinna, M. Gianfriddo, A. Melani, M. Morelli, and F. Pedata Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats Eur. J. Pharmacol. 464 2003 33 38 (Pubitemid 36205062)
    • (2003) European Journal of Pharmacology , vol.464 , Issue.1 , pp. 33-38
    • Corsi, C.1    Pinna, A.2    Gianfriddo, M.3    Melani, A.4    Morelli, M.5    Pedata, F.6
  • 11
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • DOI 10.1016/S0896-6273(03)00568-3
    • W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
    • (2003) Neuron , vol.39 , Issue.6 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 12
    • 0032817813 scopus 로고    scopus 로고
    • Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
    • DOI 10.1046/j.1471-4159.1999.0731033.x
    • P. De Deurwaerdere, and U. Spampinato Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation J. Neurochem. 73 1999 1033 1042 (Pubitemid 29395459)
    • (1999) Journal of Neurochemistry , vol.73 , Issue.3 , pp. 1033-1042
    • De Deurwaerdere, P.1    Spampinato, U.2
  • 13
    • 50649111180 scopus 로고    scopus 로고
    • Serotonin modulation of the basal ganglia circuitry: Therapeutic implication for Parkinson's disease and other motor disorders
    • V. Di Matteo, M. Pierucci, E. Esposito, G. Crescimanno, A. Benigno, and G. Di Giovanni Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders Prog. Brain Res. 172 2008 423 463
    • (2008) Prog. Brain Res. , vol.172 , pp. 423-463
    • Di Matteo, V.1    Pierucci, M.2    Esposito, E.3    Crescimanno, G.4    Benigno, A.5    Di Giovanni, G.6
  • 14
    • 0038727936 scopus 로고    scopus 로고
    • Description of Parkinson's disease as a clinical syndrome
    • S. Fahn Description of Parkinson's disease as a clinical syndrome Ann. N. Y. Acad. Sci. 991 2003 1 14 (Pubitemid 36793796)
    • (2003) Annals of the New York Academy of Sciences , vol.991 , pp. 1-14
    • Fahn, S.1
  • 15
    • 77953292667 scopus 로고    scopus 로고
    • 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease
    • M.C. Ferguson, T. Nayyar, A.Y. Deutch, and T.A. Ansah 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease Neuropharmacology 59 2010 31 36
    • (2010) Neuropharmacology , vol.59 , pp. 31-36
    • Ferguson, M.C.1    Nayyar, T.2    Deutch, A.Y.3    Ansah, T.A.4
  • 16
    • 0041317103 scopus 로고    scopus 로고
    • The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: A dual microdialysis probe analysis
    • DOI 10.1046/j.1460-9568.2003.02795.x
    • F. Galeffi, L. Bianchi, J.P. Bolam, and L. Della Corte The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis Eur. J. Neurosci. 18 2003 856 868 (Pubitemid 37059695)
    • (2003) European Journal of Neuroscience , vol.18 , Issue.4 , pp. 856-868
    • Bianchi, L.1    Galeffi, F.2    Bolam, J.P.3    Della Corte, L.4
  • 17
    • 0033008804 scopus 로고    scopus 로고
    • Serotonin (5-HT)(2A) receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats
    • DOI 10.1016/S0028-3908(98)00188-9, PII S0028390898001889
    • A. Gobert, and M.J. Millan Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats Neuropharmacology 38 1999 315 317 (Pubitemid 29073553)
    • (1999) Neuropharmacology , vol.38 , Issue.2 , pp. 315-317
    • Gobert, A.1    Millan, M.J.2
  • 18
    • 0034213062 scopus 로고    scopus 로고
    • Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
    • DOI 10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D
    • A. Gobert, J.M. Rivet, F. Lejeune, A. Newman-Tancredi, A. Adhumeau-Auclair, J.P. Nicolas, L. Cistarelli, C. Melon, and M.J. Millan Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat Synapse 36 2000 205 221 (Pubitemid 30252995)
    • (2000) Synapse , vol.36 , Issue.3 , pp. 205-221
    • Gobert, A.1    Rivet, J.-M.2    Lejeune, F.3    Newman-Tancredi, A.4    Adhumeau-Auclair, A.5    Nicolas, J.-P.6    Cistarelli, L.7    Melon, C.8    Millan, M.J.9
  • 19
    • 26944482758 scopus 로고    scopus 로고
    • L-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    • DOI 10.1016/j.neuroscience.2005.08.003, PII S0306452205008547
    • H.K. Holmer, M. Keyghobadi, C. Moore, and C.K. Meshul L-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neuroscience 136 2005 333 341 (Pubitemid 41483859)
    • (2005) Neuroscience , vol.136 , Issue.1 , pp. 333-341
    • Holmer, H.K.1    Keyghobadi, M.2    Moore, C.3    Meshul, C.K.4
  • 20
    • 81355142874 scopus 로고    scopus 로고
    • 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA
    • P. Huot, T.H. Johnston, L. Winkelmolen, S.H. Fox, and J.M. Brotchie 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA Neurobiol. Aging 33 194 2012 e195-115
    • (2012) Neurobiol. Aging , vol.33 , Issue.194
    • Huot, P.1    Johnston, T.H.2    Winkelmolen, L.3    Fox, S.H.4    Brotchie, J.M.5
  • 21
    • 0031106243 scopus 로고    scopus 로고
    • Problems with current pharmacologic treatment of Parkinson's disease
    • DOI 10.1006/exnr.1996.6380
    • H.I. Hurtig Problems with current pharmacologic treatment of Parkinson's disease Exp. Neurol. 144 1997 10 16 (Pubitemid 27149595)
    • (1997) Experimental Neurology , vol.144 , Issue.1 , pp. 10-16
    • Hurtig, H.I.1
  • 22
    • 0028971907 scopus 로고
    • DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum
    • J. Ichikawa, and H.Y. Meltzer DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum Brain Res. 698 1995 204 208
    • (1995) Brain Res. , vol.698 , pp. 204-208
    • Ichikawa, J.1    Meltzer, H.Y.2
  • 23
    • 0032526957 scopus 로고    scopus 로고
    • Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway
    • C.A. Ingham, S.H. Hood, P. Taggart, and G.W. Arbuthnott Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway J. Neurosci. 18 1998 4732 4743 (Pubitemid 28280181)
    • (1998) Journal of Neuroscience , vol.18 , Issue.12 , pp. 4732-4743
    • Ingham, C.A.1    Hood, S.H.2    Taggart, P.3    Arbuthnott, G.W.4
  • 24
    • 0027409146 scopus 로고
    • Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway
    • C.A. Ingham, S.H. Hood, B. van Maldegem, A. Weenink, and G.W. Arbuthnott Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway Exp. Brain Res. 93 1993 17 27 (Pubitemid 23104148)
    • (1993) Experimental Brain Research , vol.93 , Issue.1 , pp. 17-27
    • Ingham, C.A.1    Hood, S.H.2    Van Maldegem, B.3    Weenink, A.4    Arbuthnott, G.W.5
  • 25
    • 0036468890 scopus 로고    scopus 로고
    • MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats
    • DOI 10.1016/S0006-8993(01)03147-X, PII S000689930103147X
    • N. Jonkers, S. Sarre, G. Ebinger, and Y. Michotte MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats Brain Res. 926 2002 149 155 (Pubitemid 34117600)
    • (2002) Brain Research , vol.926 , Issue.1-2 , pp. 149-155
    • Jonkers, N.1    Sarre, S.2    Ebinger, G.3    Michotte, Y.4
  • 26
    • 0034808908 scopus 로고    scopus 로고
    • Extrapyramidal side effects are unacceptable
    • J.M. Kane Extrapyramidal side effects are unacceptable Eur. Neuropsychopharmacol. 11 Suppl 4 2001 S397 S403
    • (2001) Eur. Neuropsychopharmacol. , vol.11 , Issue.SUPPL. 4
    • Kane, J.M.1
  • 27
    • 0037449148 scopus 로고    scopus 로고
    • 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens
    • DOI 10.1016/S0006-8993(03)02516-2
    • T. Kuroki, H.Y. Meltzer, and J. Ichikawa 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens Brain Res. 972 2003 216 221 (Pubitemid 36507094)
    • (2003) Brain Research , vol.972 , Issue.1-2 , pp. 216-221
    • Kuroki, T.1    Meltzer, H.Y.2    Ichikawa, J.3
  • 28
    • 0032497504 scopus 로고    scopus 로고
    • Parkinson's disease
    • DOI 10.1056/NEJM199810083391506
    • A.E. Lang, and A.M. Lozano Parkinson's disease. First of two parts N. Engl. J. Med. 339 1998 1044 1053 (Pubitemid 28457867)
    • (1998) New England Journal of Medicine , vol.339 , Issue.15 , pp. 1044-1053
    • Lang, A.E.1    Lozano, A.M.2
  • 29
    • 0035191981 scopus 로고    scopus 로고
    • Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum
    • DOI 10.1046/j.1471-4159.2001.00644.x
    • J.C. Lievens, P. Salin, A. Nieoullon, and L. Kerkerian-Le Goff Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum J. Neurochem. 79 2001 893 902 (Pubitemid 33086527)
    • (2001) Journal of Neurochemistry , vol.79 , Issue.4 , pp. 893-902
    • Lievens, J.-C.1    Salin, P.2    Nieoullon, A.3    Goff, L.K.-L.4
  • 30
    • 0025302149 scopus 로고
    • Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons
    • DOI 10.1016/0304-3940(90)90463-J
    • N. Lindefors, and U. Ungerstedt Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons Neurosci. Lett. 115 1990 248 252 (Pubitemid 20231622)
    • (1990) Neuroscience Letters , vol.115 , Issue.2-3 , pp. 248-252
    • Lindefors, N.1    Ungerstedt, U.2
  • 31
    • 0030906167 scopus 로고    scopus 로고
    • 8-OH-DPAT, a 5-HT(1a) agonist and ritanserin, a 5-HT(2A/C) antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release
    • DOI 10.1007/s002130050265
    • G. Lucas, N. Bonhomme, P. De Deurwaerdere, M. Le Moal, and U. Spampinato 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release Psychopharmacology 131 1997 57 63 (Pubitemid 27242855)
    • (1997) Psychopharmacology , vol.131 , Issue.1 , pp. 57-63
    • Lucas, G.1    Bonhomme, N.2    De Deurwaerdere, P.3    Le Moal, M.4    Spampinato, U.5
  • 32
    • 0033621576 scopus 로고    scopus 로고
    • Role of striatal serotonin(2A) and serotonin(2C) receptor subtypes in the control of in vivo dopamine outflow in the rat striatum
    • DOI 10.1046/j.1471-4159.2000.740693.x
    • G. Lucas, and U. Spampinato Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum J. Neurochem. 74 2000 693 701 (Pubitemid 30053742)
    • (2000) Journal of Neurochemistry , vol.74 , Issue.2 , pp. 693-701
    • Lucas, G.1    Spampinato, U.2
  • 33
    • 1842524064 scopus 로고    scopus 로고
    • Glutamate transporters: Animal models to neurologic disease
    • DOI 10.1016/j.nbd.2003.12.007, PII S0969996103002729
    • N.J. Maragakis, and J.D. Rothstein Glutamate transporters: animal models to neurologic disease Neurobiol. Dis. 15 2004 461 473 (Pubitemid 38429961)
    • (2004) Neurobiology of Disease , vol.15 , Issue.3 , pp. 461-473
    • Maragakis, N.J.1    Rothstein, J.D.2
  • 35
    • 0024336026 scopus 로고
    • The organization of the projection from the cerebral cortex to the striatum in the rat
    • A.J. McGeorge, and R.L. Faull The organization of the projection from the cerebral cortex to the striatum in the rat Neuroscience 29 1989 503 537
    • (1989) Neuroscience , vol.29 , pp. 503-537
    • McGeorge, A.J.1    Faull, R.L.2
  • 36
    • 0026091799 scopus 로고
    • The mechanism of action of novel antipsychotic drugs
    • H.Y. Meltzer The mechanism of action of novel antipsychotic drugs Schizophr. Bull. 17 1991 263 287
    • (1991) Schizophr. Bull. , vol.17 , pp. 263-287
    • Meltzer, H.Y.1
  • 37
    • 0034032903 scopus 로고    scopus 로고
    • Haloperidol reverses the changes striatal glutamatergic immunolabeling following a 6-OHDA lesion
    • DOI 10.1002/(SICI)1098-2396(200005)36:2<129::AID-SYN6>3.0.CO;2-4
    • C.K. Meshul, and C. Allen Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion Synapse 36 2000 129 142 (Pubitemid 30196689)
    • (2000) Synapse , vol.36 , Issue.2 , pp. 129-142
    • Meshul, C.K.1    Allen, C.2
  • 38
    • 0033830193 scopus 로고    scopus 로고
    • Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway
    • C.K. Meshul, J.P. Cogen, H.W. Cheng, C. Moore, L. Krentz, and T.H. McNeill Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway Exp. Neurol. 165 2000 191 206
    • (2000) Exp. Neurol. , vol.165 , pp. 191-206
    • Meshul, C.K.1    Cogen, J.P.2    Cheng, H.W.3    Moore, C.4    Krentz, L.5    McNeill, T.H.6
  • 39
    • 0032889098 scopus 로고    scopus 로고
    • Time-dependent changes in striatal glutamate synapses following a 6- hydroxydopamine lesion
    • DOI 10.1016/S0306-4522(98)00189-4, PII S0306452298001894
    • C.K. Meshul, N. Emre, C.M. Nakamura, C. Allen, M.K. Donohue, and J.F. Buckman Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion Neuroscience 88 1999 1 16 (Pubitemid 28440387)
    • (1999) Neuroscience , vol.88 , Issue.1 , pp. 1-16
    • Meshul, C.K.1    Emre, N.2    Nakamura, C.M.3    Allen, C.4    Donohue, M.K.5    Buckman, J.F.6
  • 40
    • 0030662378 scopus 로고    scopus 로고
    • Regional and cellular distribution of serotonin 5-hydroxytryptamine(2a) receptor mRNA in the nucleus accumbens, olfactory tubercle, and caudate putamen of the rat
    • DOI 10.1002/(SICI)1096-9861(19971208)389:1<1::AID-CNE1>3.0.CO;2-6
    • M.J. Mijnster, A.G. Raimundo, K. Koskuba, H. Klop, G.J. Docter, H.J. Groenewegen, and P. Voorn Regional and cellular distribution of serotonin 5-hydroxytryptamine2a receptor mRNA in the nucleus accumbens, olfactory tubercle, and caudate putamen of the rat J. Comp. Neurol. 389 1997 1 11 (Pubitemid 27476197)
    • (1997) Journal of Comparative Neurology , vol.389 , Issue.1 , pp. 1-11
    • Mijnster, M.J.1    Raimundo, A.G.V.2    Koskuba, K.3    Klop, H.4    Docter, G.J.5    Groenewegen, H.J.6    Voorn, P.7
  • 41
    • 0033923055 scopus 로고    scopus 로고
    • Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance
    • C.A. Murphy, and J. Feldon Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance Behav. Pharmacol. 11 2000 307 316 (Pubitemid 30449762)
    • (2000) Behavioural Pharmacology , vol.11 , Issue.3-4 , pp. 307-316
    • Murphy, C.A.1    Feldon, J.2
  • 43
    • 0025355032 scopus 로고
    • Levodopa-induced dyskinesia: Review, observations, and speculations
    • J.G. Nutt Levodopa-induced dyskinesia: review, observations, and speculations Neurology 40 1990 340 345 (Pubitemid 20099455)
    • (1990) Neurology , vol.40 , Issue.2 , pp. 340-345
    • Nutt, J.G.1
  • 44
    • 24344446871 scopus 로고    scopus 로고
    • Diagnosis and initial management of Parkinson's disease
    • DOI 10.1056/NEJMcp043908
    • J.G. Nutt, and G.F. Wooten Clinical practice. Diagnosis and initial management of Parkinson's disease N. Engl. J. Med. 353 2005 1021 1027 (Pubitemid 41262336)
    • (2005) New England Journal of Medicine , vol.353 , Issue.10 , pp. 1021-1027
    • Nutt, J.G.1    Wooten, G.F.2
  • 45
    • 0033695441 scopus 로고    scopus 로고
    • Levodopa motor complications in Parkinson's disease
    • J.A. Obeso, C.W. Olanow, and J.G. Nutt Levodopa motor complications in Parkinson's disease Trends Neurosci. 23 2000 S2 S7
    • (2000) Trends Neurosci. , vol.23
    • Obeso, J.A.1    Olanow, C.W.2    Nutt, J.G.3
  • 46
    • 0028176806 scopus 로고
    • Distribution of the serotonin 5-HT2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors
    • M. Pompeiano, J.M. Palacios, and G. Mengod Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors Brain Res. Mol. Brain Res. 23 1994 163 178
    • (1994) Brain Res. Mol. Brain Res. , vol.23 , pp. 163-178
    • Pompeiano, M.1    Palacios, J.M.2    Mengod, G.3
  • 47
    • 0036008435 scopus 로고    scopus 로고
    • 2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum
    • DOI 10.1016/S0893-133X(01)00333-5, PII S0893133X01003335
    • G. Porras, V. Di Matteo, C. Fracasso, G. Lucas, P. De Deurwaerdere, S. Caccia, E. Esposito, and U. Spampinato 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum Neuropsychopharmacology 26 2002 311 324 (Pubitemid 34159209)
    • (2002) Neuropsychopharmacology , vol.26 , Issue.3 , pp. 311-324
    • Porras, G.1    Di Matteo, V.2    Fracasso, C.3    Lucas, G.4    De Deurwaerdere, P.5    Caccia, S.6    Esposito, E.7    Spampinato, U.8
  • 48
    • 79955948512 scopus 로고    scopus 로고
    • Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias
    • G. Riahi, M. Morissette, M. Parent, and T. Di Paolo Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias Eur. J. Neurosci. 33 2011 1823 1831
    • (2011) Eur. J. Neurosci. , vol.33 , pp. 1823-1831
    • Riahi, G.1    Morissette, M.2    Parent, M.3    Di Paolo, T.4
  • 49
    • 4544347756 scopus 로고    scopus 로고
    • Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease
    • DOI 10.1111/j.1460-9568.2004.03591.x
    • S. Robelet, C. Melon, B. Guillet, P. Salin, and L. Kerkerian-Le Goff Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease Eur. J. Neurosci. 20 2004 1255 1266 (Pubitemid 39233578)
    • (2004) European Journal of Neuroscience , vol.20 , Issue.5 , pp. 1255-1266
    • Robelet, S.1    Melon, C.2    Guillet, B.3    Salin, P.4    Kerkerian-Le Goff, L.5
  • 50
    • 33745776519 scopus 로고    scopus 로고
    • ACP-103, a 5-HT2A receptor inverse agonist
    • C. Roberts ACP-103, a 5-HT2A receptor inverse agonist Curr. Opin. Investig. Drugs 7 2006 653 660
    • (2006) Curr. Opin. Investig. Drugs , vol.7 , pp. 653-660
    • Roberts, C.1
  • 51
    • 0037349708 scopus 로고    scopus 로고
    • Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function
    • S. Robinson, P. Freeman, C. Moore, J.C. Touchon, L. Krentz, and C.K. Meshul Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function Exp. Neurol. 180 2003 74 87
    • (2003) Exp. Neurol. , vol.180 , pp. 74-87
    • Robinson, S.1    Freeman, P.2    Moore, C.3    Touchon, J.C.4    Krentz, L.5    Meshul, C.K.6
  • 52
    • 0030438479 scopus 로고    scopus 로고
    • Regional effects of MK-801 on dopamine release: Effects of competitive NMDA or 5-HT2A receptor blockade
    • C.J. Schmidt, and G.M. Fadayel Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade J. Pharmacol. Exp. Ther. 277 1996 1541 1549
    • (1996) J. Pharmacol. Exp. Ther. , vol.277 , pp. 1541-1549
    • Schmidt, C.J.1    Fadayel, G.M.2
  • 53
    • 0028176861 scopus 로고
    • Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine
    • C.J. Schmidt, C.K. Sullivan, and G.M. Fadayel Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine J. Neurochem. 62 1994 1382 1389
    • (1994) J. Neurochem. , vol.62 , pp. 1382-1389
    • Schmidt, C.J.1    Sullivan, C.K.2    Fadayel, G.M.3
  • 54
    • 0034551757 scopus 로고    scopus 로고
    • DOI-Induced activation of the cortex: Dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons
    • J.L. Scruggs, S. Patel, M. Bubser, and A.Y. Deutch DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons J. Neurosci. 20 2000 8846 8852
    • (2000) J. Neurosci. , vol.20 , pp. 8846-8852
    • Scruggs, J.L.1    Patel, S.2    Bubser, M.3    Deutch, A.Y.4
  • 55
    • 0037630660 scopus 로고    scopus 로고
    • The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats
    • DOI 10.1016/S0304-3940(03)00547-0
    • J.L. Scruggs, D. Schmidt, and A.Y. Deutch The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats Neurosci. Lett. 346 2003 137 140 (Pubitemid 36829280)
    • (2003) Neuroscience Letters , vol.346 , Issue.3 , pp. 137-140
    • Scruggs, J.L.1    Schmidt, D.2    Deutch, A.Y.3
  • 56
    • 34848842158 scopus 로고    scopus 로고
    • The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
    • DOI 10.1016/j.neuint.2007.03.012, PII S0197018607000770
    • A.L. Sheldon, and M.B. Robinson The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention Neurochem. Int. 51 2007 333 355 (Pubitemid 47503456)
    • (2007) Neurochemistry International , vol.51 , Issue.6-7 , pp. 333-355
    • Sheldon, A.L.1    Robinson, M.B.2
  • 58
    • 0037316679 scopus 로고    scopus 로고
    • The 'glial' glutamate transporter, EAAT2 (G1t-1) accounts for high affinity glutamate uptake into adult rodent nerve endings
    • DOI 10.1046/j.1471-4159.2003.01553.x
    • S.K. Suchak, N.V. Baloyianni, M.S. Perkinton, R.J. Williams, B.S. Meldrum, and M. Rattray The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings J. Neurochem. 84 2003 522 532 (Pubitemid 36182251)
    • (2003) Journal of Neurochemistry , vol.84 , Issue.3 , pp. 522-532
    • Suchak, S.K.1    Baloyianni, N.V.2    Perkinton, M.S.3    Williams, R.J.4    Meldrum, B.S.5    Rattray, M.6
  • 59
    • 33646488703 scopus 로고    scopus 로고
    • Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat
    • J.L. Taylor, C. Bishop, T. Ullrich, K.C. Rice, and P.D. Walker Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat Neuropharmacology 50 2006 761 768
    • (2006) Neuropharmacology , vol.50 , pp. 761-768
    • Taylor, J.L.1    Bishop, C.2    Ullrich, T.3    Rice, K.C.4    Walker, P.D.5
  • 61
    • 67649671927 scopus 로고    scopus 로고
    • Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum
    • R.H. Walker, R.J. Koch, J.E. Sweeney, C. Moore, and C.K. Meshul Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum NeuroReport 20 2009 770 775
    • (2009) NeuroReport , vol.20 , pp. 770-775
    • Walker, R.H.1    Koch, R.J.2    Sweeney, J.E.3    Moore, C.4    Meshul, C.K.5
  • 62
    • 0030018405 scopus 로고    scopus 로고
    • Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum
    • DOI 10.1002/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2- R
    • R.P. Ward, and D.M. Dorsa Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum J. Comp. Neurol. 370 1996 405 414 (Pubitemid 26235237)
    • (1996) Journal of Comparative Neurology , vol.370 , Issue.3 , pp. 405-414
    • Ward, R.P.1    Dorsa, D.M.2
  • 63
    • 0025327731 scopus 로고
    • Unbiased stereological estimation of the number of neurons in the human hippocampus
    • DOI 10.1002/cne.902960102
    • M.J. West, and H.J. Gundersen Unbiased stereological estimation of the number of neurons in the human hippocampus J. Comp. Neurol. 296 1990 1 22 (Pubitemid 20174971)
    • (1990) Journal of Comparative Neurology , vol.296 , Issue.1 , pp. 1-22
    • West, M.J.1    Gundersen, H.J.G.2
  • 64
    • 0023619422 scopus 로고
    • The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis
    • B.H. Westerink, J. Tuntler, G. Damsma, H. Rollema, and J.B. de Vries The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis Naunyn-Schmiedeberg's Arch. Pharmacol. 336 1987 502 507 (Pubitemid 17166839)
    • (1987) Naunyn-Schmiedeberg's Archives of Pharmacology , vol.336 , Issue.5 , pp. 502-507
    • Westerink, B.H.C.1    Tuntler, J.2    Damsma, G.3    Rollema, H.4    De Vries, J.B.5
  • 65
    • 0033060133 scopus 로고    scopus 로고
    • Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: A regionally-specific double dissociation
    • DOI 10.1007/s002130051001
    • C.D. Young, M. Bubser, H.Y. Meltzer, and A.Y. Deutch Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation Psychopharmacology 144 1999 255 263 (Pubitemid 29307277)
    • (1999) Psychopharmacology , vol.144 , Issue.3 , pp. 255-263
    • Young, C.D.1    Bubser, M.2    Meltzer, H.Y.3    Deutch, A.Y.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.